Geneos Wealth Management’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-328
Closed -$59K 2872
2021
Q3
$59K Hold
328
﹤0.01% 1410
2021
Q2
$51K Sell
328
-191
-37% -$25.8K ﹤0.01% 1475
2021
Q1
$72K Hold
519
﹤0.01% 1440
2020
Q4
$57K Buy
519
+428
+470% +$34.8K ﹤0.01% 1398
2020
Q3
$7K Buy
+91
New +$7.19K ﹤0.01% 2088
2017
Q1
Sell
-100
Closed -$5K 2136
2016
Q4
$5K Hold
100
﹤0.01% 1646
2016
Q3
$5K Hold
100
﹤0.01% 1589
2016
Q2
$5K Hold
100
﹤0.01% 1533
2016
Q1
$7K Buy
+100
New +$7.58K ﹤0.01% 1421

Other funds holding SYNA

Geneos Wealth Management's SYNA Position: Q4 2021 in Review

Geneos Wealth Management sold out of Synaptics (SYNA) in Q4 2021, closing a stake of 328 shares — an estimated $59K sold.

Geneos Wealth Management first reported a position in SYNA in Q1 2016 and held it in 9 quarters. The position peaked at $72K in Q1 2021. 363 funds tracked by Wall St. Rank hold SYNA as of Q4 2021.

  • Geneos Wealth Management reported no remaining Synaptics position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 328 Synaptics shares in Q4 2021, an estimated $59K.
  • Geneos Wealth Management first reported a position in Synaptics in Q1 2016 and held it in 9 quarters.
  • Geneos Wealth Management's Synaptics position peaked at $72K in Q1 2021.
  • 363 funds tracked by Wall St. Rank held Synaptics as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.